Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Communicable Diseases Intelligence (2018)|October 21, 2025
Australian Rotavirus Surveillance Program: Annual Report, 2024Sarah Thomas, Nada Bogdanovic-Sakran, Daniel Pavlic, et al.
Human Vaccines & Immunotherapeutics|April 25, 2018
Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccineDaniel Cowley, Daniel Pavlic, Nada Bogdanovic-Sakran, et al.
Communicable Diseases Intelligence (2018)|May 18, 2025
Australian Rotavirus Surveillance Program Annual Report, 2023Sarah Thomas, Nada Bogdanovic-Sakran, Celeste M Donato, et al.
Human Vaccines & Immunotherapeutics|January 7, 2017
Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New ZealandMee-Yew Chen, Carl D Kirkwood, Julie Bines, et al.
Vaccine|March 13, 2020
Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, IndonesiaMargie H Danchin, Julie E Bines, Emma Watts, et al.
The Journal of Infectious Diseases|August 18, 2023
Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA StatusCeleste M Donato, Amanda Handley, Sean G Byars, et al.
The Lancet. Infectious Diseases|January 23, 2022
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging studyDesiree Witte, Amanda Handley, Khuzwayo C Jere, et al.
Viruses|September 28, 2024
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in MalawiBenjamin Morgan, Eleanor A Lyons, Amanda Handley, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 1